Healthcare -
Biotechnology - NASDAQ - US
$ 14.13
-4.33 %
$ 1.44 B
Market Cap
-3.95
P/E
DYN - TOTAL CURRENT ASSETS
Total Current Assets DYN - Dyne Therapeutics, Inc.
129 M
LAST VALUE
-41.83%
2 YEAR CAGR
73.80%
5 YEAR CAGR
-22.64%
10 YEAR CAGR